Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| TNF | Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppression | Cancer Sci., 2011 Apr | Antibody | AP20373PU-N |
| TNF | Methylprednisolone fails to preserve pulmonary surfactant and blood-air barrier integrity in a porcine cardiopulmonary bypass model. | The Journal of surgical research, 2008 May | Antibody | PP1071P2 |
| Tnf | Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats. | Journal of neuroscience research, 2007 Nov | Antibody | TA328597 |
| Tnf | Progressive loss of myocardial contractile function despite unimpaired coronary blood flow after cardiac surgery. | Basic research in cardiology, 2005 Dec | Antibody | TA328558 |
| TNF alpha | Duhuo Jisheng Decoction inhibits SDF-1-induced inflammation and matrix degradation in human degenerative nucleus pulposus cells in vitro through the CXCR4/NF-κB pathway | Acta Pharmacol. Sin., 2018 May | Antibody | TA506513S |
| TNFAIP3 | The Effects of Interleukin-17 (IL-17)-Related Inflammatory Cytokines and A20 Regulatory Proteins on Astrocytes in Spinal Cord Cultured In Vitro | Cell. Physiol. Biochem., 2016 Mar | Antibody | TA306764 |
| TNFRSF10B | Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer | Cell Death & Disease, 2023 Apr | Antibody | TA807279 |
| TNFRSF10D | Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models | Clin. Cancer Res., 2015 Jul | Antibody | TA305975 |
| TNFRSF11A | RANKL/RANK control Brca1 mutation-driven mammary tumors | Cell Research, 2016 Jul | Antibody | TA336373 |
| TNFRSF11B | Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients | PLoS ONE, 2019 Dec | Antibody | AM06539SU-N |
| TNFRSF11B | SIRT6 deficiency culminates in low-turnover osteopenia | Bone, 2015 Jul | Antibody | TA322994 |
| TNFRSF11B | Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. | Molecular and cellular endocrinology, 2012 Jun | Antibody | AP06631PU-N |
| TNFRSF8 | T cell receptor rearrangements in a patient with γ-heavy chain disease: A case report | Oncology Letters, 2016 Jun | Antibody | TA801630 |
| TNFSF11 | Impact of phosphorylation of heat shock protein 27 on the expression profile of periodontal ligament fibroblasts during mechanical strain | Journal of Orofacial Orthopedics, 2022 Apr | Antibody | TA306362 |
| TNFSF11 | High-mobility group box 1 released by traumatic occlusion accelerates bone resorption in the root furcation area in mice | Journal of periodontal research, 2020 Nov | Antibody | TA327378 |
| TNFSF11 | Effects of histamine on human periodontal ligament fibroblasts under simulated orthodontic pressure | PLoS ONE, 2020 Aug | Antibody | TA306362 |
| TNFSF11 | Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL | Cancers (Basel) 2019, 2019 Feb | Antibody | TA327378 |
| TNFSF11 | Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system | Mediterranean Journal of Rheumatology, 2018 Dec | Antibody | PM1211P |
| TNFSF11 | Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. | Molecular and cellular endocrinology, 2012 Jun | Antibody | PP1086P1 |
| TNNI3 | Antibody-Oriented Strategy and Mechanism for the Preparation of Fluorescent Nanoprobes for Fast and Sensitive Immunodetection | Langmuir, 2019 Mar | Antibody | TA807911 |
| TNNI3 | Antibody-Oriented Strategy and Mechanism for the Preparation of Fluorescent Nanoprobes for Fast and Sensitive Immunodetection | Langmuir, 2019 Mar | Antibody | TA700515 |
| TNNI3 | Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry | Stem Cell Reports, 2019 Feb | Antibody | TA303719 |
| TNNI3 | Characterization and validation of new tools for measuring site-specific cardiac troponin I phosphorylation | J. Immunol. Methods, 2018 Nov | Antibody | AP26441PU-N |
| TNNI3 | Fluorescent Nanoprobes with Oriented Modified Antibodies to Improve Lateral Flow Immunoassay of Cardiac Troponin I | Anal. Chem., 2018 May | Antibody | TA807911 |
| TNNI3 | Fluorescent Nanoprobes with Oriented Modified Antibodies to Improve Lateral Flow Immunoassay of Cardiac Troponin I | Anal. Chem., 2018 May | Antibody | TA700515 |
| TNNI3 | Re-programming of newt cardiomyocytes is induced by tissue regeneration | J. Cell. Sci., 2015 Oct | Antibody | BM748X |
| TNNI3 | Re-programming of newt cardiomyocytes is induced by tissue regeneration | J. Cell. Sci., 2015 Oct | Antibody | BM750 |
| TNNT2 | Activated Cardiac Fibroblasts Control Contraction of Human Fibrotic Cardiac Microtissues by a β-Adrenoreceptor-Dependent Mechanism | Cells, 2020 May | Antibody | AP55359SU-N |
| TOP1 | Partial Purification of a Megadalton DNA Replication Complex by Free Flow Electrophoresis | PLoS ONE, 2016 Dec | Antibody | TA307877 |
| TOP2A | Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer | Breast Cancer, 2020 Aug | Antibody | TA802684 |
| TOP2A | Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity | Oncotarget, 2018 Jan | Antibody | UM870043 |
| TOP2A | Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines | BMC Cancer, 2016 Jan | Antibody | TA303723 |
| TP53 | Genetic mutations in ribosomal biogenesis gene TCOF1 identified in human neural tube defects. | Molecular genetics & genomic medicine, 2023 May | Antibody | TA804804 |
| TP53 | Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis | Nature Communications, 2023 May | Antibody | TA502870 |
| TP53 | Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma | World Journal of Surgical Oncology, 2022 Dec | Antibody | SM2139PT |
| TP53 | TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis | Frontiers in Oncology, 2022 Mar | Antibody | UM570053 |
| TP53 | Protective effects of exosomes derived from lyophilized porcine liver against acetaminophen damage on HepG2 cells | BMC Complementary Medicine and Therapies, 2021 Dec | Antibody | TA326166 |
| TP53 | MDM2 induces EMT via the B‑Raf signaling pathway through 14‑3‑3 | Oncology reports, 2021 Jul | Antibody | TA808657 |
| TP53 | Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases | Annals of Translational Medicine, 2021 Apr | Antibody | SM2139PT |
| TP53 | Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases. | Human pathology, 2020 Oct | Antibody | SM2139PT |
| TP53 | Pathological Prognostic Factors of Pseudomyxoma Peritonei:Comprehensive Clinicopathological Analysis of 155 Cases | Hum. Pathol., 2020 Jan | Antibody | TA327719 |
| TP53 | Bio-fabrication of pigment-capped silver nanoparticles encountering antibiotic-resistant strains and their cytotoxic effect towards human epidermoid larynx carcinoma (HEp-2) cells | RSC Adv., 2019 May | Antibody | TA327920 |
| TP53 | Mongolian Medicine RuXian-I Treatment of Estrogen-Induced Mammary Gland Hyperplasia in Rats Related to TCTP Regulating Apoptosis | Evidence-Based Complementary and Alternative Medicine, 2019 Mar | Antibody | TA502870 |
| TP53 | Upregulated expression of AT-rich interactive domain-containing protein 1B predicts poor prognosis in patients with triple-negative breast cancer | Oncol Lett, 2019 Mar | Antibody | TA502780 |
| TP53 | Isolated Langerhans cell histiocytosis of the stomach: a case report and literature review | International Journal of Clinical and Experimental Pathology, 2018 Dec | Antibody | SM2139PT |
| TP53 | Clinicopathologic study on a rare variant of ameloblastoma with basal cell features | Oral Dis, 2018 Dec | Antibody | TA808657 |
| TP53 | Functional role of RRS1 in breast cancer cell proliferation | J. Cell. Mol. Med., 2018 Oct | Antibody | TA808657 |
| TP53 | Prediction model of lymphovascular invasion based on clinicopathological factors in Chinese patients with invasive breast cancer | Medicine, 2018 Oct | Antibody | UM500053 |
| TP53 | Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways | Oncogene, 2018 Aug | Antibody | AM03100PU-N |
| TP53 | Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer | Oncol Lett, 2016 Oct | Antibody | TA502780 |
Germany
Japan
United Kingdom
China